Use of the somatostatin analogue octreotide acetate in the treatment of encephalopathy associated with carcinoid tumor. Case report.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 9391539)

Published in Am J Clin Oncol on December 01, 1997

Authors

L L Siu1, W Chapman, M J Moore

Author Affiliations

1: Department of Medicine, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada.

Articles by these authors

(truncated to the top 100)

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol (1997) 29.02

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med (2000) 18.12

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol (2000) 8.08

The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions. EMBO J (2000) 7.54

The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. J Clin Oncol (1996) 7.02

The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. EMBO J (2001) 5.69

A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. Ann Oncol (1996) 4.07

Pre-mRNA splicing alters mRNP composition: evidence for stable association of proteins at exon-exon junctions. Genes Dev (2000) 3.74

Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding. J Exp Med (1990) 3.01

Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma. Canadian Urologic Oncology Group. N Engl J Med (1998) 2.85

Branch nucleophile selection in pre-mRNA splicing: evidence for the bulged duplex model. Genes Dev (1994) 2.63

Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ (2000) 2.36

Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol (1998) 2.36

Eye contact and face scanning in early infancy. Science (1977) 2.20

Structure of the detoxification catalyst mercuric ion reductase from Bacillus sp. strain RC607. Nature (1991) 2.01

The human Prp8 protein is a component of both U2- and U12-dependent spliceosomes. RNA (1999) 1.81

Syndrome and outbreak detection using chief-complaint data--experience of the Real-Time Outbreak and Disease Surveillance project. MMWR Morb Mortal Wkly Rep (2004) 1.78

Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence. Aliment Pharmacol Ther (2006) 1.74

Precursor RNAs harboring nonsense codons accumulate near the site of transcription. Mol Cell (2001) 1.72

Bimolecular exon ligation by the human spliceosome. Science (1997) 1.72

The C-terminal region of hPrp8 interacts with the conserved GU dinucleotide at the 5' splice site. RNA (1999) 1.71

Use of a site-directed triple mutant to trap intermediates: demonstration that the flavin C(4a)-thiol adduct and reduced flavin are kinetically competent intermediates in mercuric ion reductase. Biochemistry (1990) 1.63

Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years. Gynecol Oncol (2001) 1.61

Removing a barrier to computer-based outbreak and disease surveillance--the RODS Open Source Project. MMWR Morb Mortal Wkly Rep (2004) 1.60

Deadly diving? Physiological and behavioural management of decompression stress in diving mammals. Proc Biol Sci (2011) 1.57

Repair of a traumatically amputated penis with return of erectile function. J Urol (1991) 1.53

Linkage of susceptibility to experimental allergic encephalomyelitis to the major histocompatibility locus in the rat. J Exp Med (1973) 1.53

Intravenous diazepam in the treatment of prolonged seizure activity. N Engl J Med (1967) 1.50

The obstacles to maximising the impact of public access defibrillation: an assessment of the dispatch mechanism for out-of-hospital cardiac arrest. Heart (2007) 1.46

Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group. CMAJ (2000) 1.43

Biphasic energy selection for transthoracic cardioversion of atrial fibrillation. The BEST AF Trial. Heart (2007) 1.42

Intron recognition comes of AGe. Nat Struct Biol (2000) 1.38

Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain. J Clin Oncol (2003) 1.35

Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications. Clin Cancer Res (2001) 1.33

Biometric analyses of normal skeletal muscle. Acta Neuropathol (1971) 1.31

How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol (2002) 1.28

Drinking and schooling. J Health Econ (1993) 1.24

Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer. Br J Cancer (2006) 1.24

Strychnine blocks binaural inhibition in lateral superior olivary neurons. J Neurosci (1983) 1.23

Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group. J Clin Oncol (2005) 1.21

Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivity. Cancer Res (2000) 1.20

Molecular basis of bacterial resistance to organomercurial and inorganic mercuric salts. FASEB J (1988) 1.19

Evidence for a linear search in bimolecular 3' splice site AG selection. Proc Natl Acad Sci U S A (2000) 1.17

Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points. J Clin Oncol (1998) 1.17

Animal models of spinal cord injury for evaluation of tissue engineering treatment strategies. Biomaterials (2004) 1.13

Evidence for the participation of Cys558 and Cys559 at the active site of mercuric reductase. Biochemistry (1989) 1.12

High risk of vascular events in patients with urothelial transitional cell carcinoma treated with cisplatin based chemotherapy. J Urol (1998) 1.12

Prostate cancer: 9. Treatment of advanced disease. CMAJ (1999) 1.10

Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on g protein-mediated activation of mitogen-activated protein kinases. J Biol Chem (2001) 1.09

Effects on DNA integrity and apoptosis induction by a novel antitumor sesquiterpene drug, 6-hydroxymethylacylfulvene (HMAF, MGI 114). Biochem Pharmacol (1997) 1.07

The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers--a study of the National Cancer Institute of Canada Clinical Trials Group. Int J Gynecol Cancer (2004) 1.06

Mechanisms of gastroesophageal reflux. N Engl J Med (1983) 1.06

Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors. J Clin Oncol (2000) 1.06

Retracted Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer. Ann Oncol (2006) 1.05

Caregiver time use: an outcome measure in clinical trial research on Alzheimer's disease. Clin Pharmacol Ther (1995) 1.05

Better conditions for mammalian in vitro splicing provided by acetate and glutamate as potassium counterions. Nucleic Acids Res (2000) 1.04

Linkage of severity of experimental allergic encephalomyelitis to the rat major histocompatibility locus. J Immunol (1980) 1.02

Removal of glass coverslips from cultures flat embedded in epoxy resins using hydrofluoric acid. J Microsc (1975) 1.02

Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome. Radiother Oncol (1999) 1.01

Comorbidity, age and overall survival in patients with advanced pancreatic cancer - results from NCIC CTG PA.3: a phase III trial of gemcitabine plus erlotinib or placebo. Eur J Cancer (2011) 1.00

Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience. Ann Oncol (2004) 0.99

Variations in muscle status with age and systemic diseases. Acta Neuropathol (1972) 0.99

A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret hospital Phase II consortium. Invest New Drugs (2007) 0.98

Cutaneous metastatic adenocarcinoma of gallbladder origin. Arch Dermatol (1982) 0.96

Mutations in c-Ki-ras oncogenes in diseased livers of winter flounder from Boston Harbor. Proc Natl Acad Sci U S A (1990) 0.96

Domain analysis of human U5 RNA. Cap trimethylation, protein binding, and spliceosome assembly. J Biol Chem (1996) 0.95

Localization of theta alloantigens in mouse brain by immunofluroescence and cytotoxic inhibition. Brain Res (1971) 0.95

Altruistic living donors: evaluation for nondirected kidney or liver donation. Am J Transplant (2006) 0.95

The unidentified interstellar infrared bands: PAHs as carriers? Science (1994) 0.93

A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer. Br J Cancer (2005) 0.93

Active site of mercuric reductase resides at the subunit interface and requires Cys135 and Cys140 from one subunit and Cys558 and Cys559 from the adjacent subunit: evidence from in vivo and in vitro heterodimer formation. Biochemistry (1990) 0.93

Metastatic cancer without a detectable primary site. Am J Surg (1967) 0.93

Bubbles in live-stranded dolphins. Proc Biol Sci (2011) 0.93

99Tcm-sestamibi imaging of inhibition of the multidrug resistance transporter in a mouse xenograft model of human breast cancer. Nucl Med Commun (1999) 0.92

Four cases of traumatic optic nerve blindness in the horse. Equine Vet J (1986) 0.92

Selective diffusion of neutral amino acids across lipid bilayers. Biochim Biophys Acta (1971) 0.92

Attenuation and activation characteristics of steel and tungsten and the suitability of these materials for use in a fast neutron multileaf collimator. Med Phys (2001) 0.90

Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells. J Nucl Med (1996) 0.90

Splenic infarction and spontaneous rupture of the spleen after therapeutic embolization. Cardiovasc Radiol (1978) 0.89

The effects of short-term variation in abortion funding on pregnancy outcomes. J Health Econ (1999) 0.89

Acute disseminated encephalomyelitis. Br J Clin Pract (1974) 0.89

Human carbonic anhydrases. VII. A new C type isozyme in erythrocytes of American Negroes. Biochem Genet (1971) 0.88

Bimolecular exon ligation by the human spliceosome bypasses early 3' splice site AG recognition and requires NTP hydrolysis. RNA (2000) 0.88

A quantitative ultrastructural study of collagen fibril formation in the healing extensor digitorum longus tendon of the rat. J Hand Surg Br (1987) 0.88

Acute necrotizing hemorrhagic encephalopathy. Postgrad Med (1973) 0.88

EAE in rat bone marrow chimeras: analysis of the cellular mechanism of BN resistance. J Immunol (1981) 0.87

p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance. Cancer J (2001) 0.87

Genetic control of thymus-derived cell function. IV. Mitogen responsiveness and mixed lymphocyte reactivity of thymus cells and lymph node cells from Lewis and Brown Norway rats. J Immunol (1973) 0.86

Characterization of virus-specific T-cell immunity in liver allograft recipients with HCV-induced cirrhosis. Am J Transplant (2008) 0.85

Elevated ornithine decarboxylase activity, polyamines and cell proliferation in neoplastic and vacuolated liver cells of winter flounder (Pleuronectes americanus) Carcinogenesis (1993) 0.85

Collagen fibril morphometry in transected rat extensor tendons. J Anat (1991) 0.84

Urinary calcium excretion in human beings. N Engl J Med (1979) 0.84

Adjuvant chemotherapy for high-risk urothelial transitional cell carcinoma: the Princess Margaret Hospital experience. Br J Urol (1998) 0.84

Decompression sickness ('the bends') in sea turtles. Dis Aquat Organ (2014) 0.83

Maintenance of progesterone-facilitated sexual behavior in female rats requires continued hypothalamic protein synthesis and nuclear progestin receptor occupation. Endocrinology (1987) 0.83

Assessment of tumor cell repopulation after chemotherapy for advanced ovarian cancer: pilot study. Cytometry A (2003) 0.82

Determination of lovastatin in human plasma using reverse-phase high-performance liquid chromatography with UV detection. Ther Drug Monit (2000) 0.82

Breastfeeding during pregnancy. J Hum Lact (1993) 0.82

A retrospective analysis of the relationship between changes in serum PSA, palliative response and survival following systemic treatment in a Canadian randomized trial for symptomatic hormone-refractory prostate cancer. Ann Oncol (2001) 0.82